SUMOylation of SMAD4 by PIAS1 in Conjunction with Vimentin Upregulation Promotes Migration Potential in Non-Small Cell Lung Cancer
Frontiers in Bioscience-Landmark · 2023
DOI: 10.31083/j.fbl2808192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2023. Verfasst von Chunli Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory, Ningbo No.2 Hospital, 315000 Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Reasearch Foundation of Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo Health Branding Subject Fund, Basic Public Welfare Research Program of Zhejiang Province.
Abstract (Originalsprache)
Background
The expression of vimentin as a marker of epithelial-to-mesenchymal transition (EMT) has been speculated to be associated with tissue heterogeneity and metastases of non-small cell lung cancer (NSCLC).
Methods
This study utilized in vitro co-immunoprecipitation with small interfering RNAs (siRNAs) against protein inhibitors of STAT system type 1 (PIAS1) or SMAD4 in transforming growth factor-beta (TGF-β) signaling pathway in combination with SUMOylation assay.
Results
We successfully demonstrated that PIAS1 enhanced SUMOylation of SMAD4 by forming a complex PIAS1-SUMO1-SMAD4 protein complex. This, in accordance with subsequently increased production of vimentin microfilaments, led to enhanced migration ability of non-small cell lung cancer (NSCLC) A549 line, observed from wound healing assay.
Conclusions
Our results further supported the positive correlation of SUMOylated SMAD4 mediated by PIAS1 and downstream overexpression of vimentin. In addition, the observation that overexpression of vimentin in this certain cell line was not necessarily linked with accelerated relative wound closure raised concerns that further exploration will be needed to confirm if the causal relationship exists between vimentin expression and the metastases of NSCLC, and if so, to what extent vimentin contributes to it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory, Ningbo No.2 Hospital, 315000 Ningbo, Zhejiang, China.
- Department of Radiology, Ningbo No.2 Hospital, 315000 Ningbo, Zhejiang, China.
Förderung
- Key Reasearch Foundation of Hwa Mei Hospital, University of Chinese Academy of Sciences
- Ningbo Health Branding Subject Fund
- Basic Public Welfare Research Program of Zhejiang Province
- Medical Scientific Research Foundation of Zhejiang Province
- Ningbo Clinical Research Center for Respiratory System Disease of Zhejiang Province
Zitieren
APA
Wu, C., Zhu, X., Dai, Q., Chu, Z., Yang, S., & Dong, Z. (2023). SUMOylation of SMAD4 by PIAS1 in Conjunction with Vimentin Upregulation Promotes Migration Potential in Non-Small Cell Lung Cancer. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2808192
Vancouver
Wu C, Zhu X, Dai Q, Chu Z, Yang S, Dong Z. SUMOylation of SMAD4 by PIAS1 in Conjunction with Vimentin Upregulation Promotes Migration Potential in Non-Small Cell Lung Cancer. Frontiers in Bioscience-Landmark. 2023. doi:10.31083/j.fbl2808192
BibTeX
@article{Wu2023,
author = {Wu, Chunli and Zhu, Xiaoxiao and Dai, Qi and Chu, Zanbo and Yang, Sijia and Dong, Zhaoxing},
title = {SUMOylation of SMAD4 by PIAS1 in Conjunction with Vimentin Upregulation Promotes Migration Potential in Non-Small Cell Lung Cancer},
journal = {Frontiers in Bioscience-Landmark},
year = {2023},
doi = {10.31083/j.fbl2808192}
}
EUVIMED